Skip to content 
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified. more
| Time Frame | LABU | S&P500 |
|---|---|---|
| 1-Week Return | 12.12% | 1.08% |
| 1-Month Return | -1.55% | 1.06% |
| 3-Month Return | 10.65% | 5.86% |
| 6-Month Return | 52.67% | 8.51% |
| 1-Year Return | 105.49% | 12.33% |
| 3-Year Return | 396.06% | 85.91% |
| 5-Year Return | -75.94% | 68.16% |
| 10-Year Return | -55.62% | 263.81% |
| Stock name | Ticker | Weight |
|---|---|---|
 SPSIBI SWAP ASSET LEG (SPSIBICTL) | SPSIBI.SWAP.ASSET.LEG..SPSIBICTL. | 15.36% |
 SPSIBI SWAP ASSET LEG (SPSIBIUBL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIUBL. | 14.89% |
 SPSIBI SWAP ASSET LEG (SPSIBIMLL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIMLL. | 13.56% |
 SPSIBI SWAP ASSET LEG (SPSIBIBCL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBCL. | 10.77% |
 SPSIBI SWAP ASSET LEG (SPSIBIJPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIJPL. | 9.13% |
 GOLDMAN FINL SQ TRSRY INST 506 | GOLDMAN.FINL.SQ.TRSRY.INST.506 | 5.55% |
 DREYFUS GOVT CASH MAN INS | DREYFUS.GOVT.CASH.MAN.INS | 4.73% |
 SPSIBI SWAP ASSET LEG (SPSIBIBPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBPL. | 4.63% |
 SPSIBI SWAP ASSET LEG (SPSIBIGSL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIGSL. | 0.8% |
 MODERNA INC | MRNA | 0.46% |
 NATERA INC | NTRA | 0.37% |
 BIOGEN INC | BIIB | 0.37% |
 HALOZYME THERAPEUTICS INC | HALO | 0.35% |
 UNITED THERAPEUTICS CORP | UTHR | 0.35% |
 AMGEN INC | AMGN | 0.35% |
 ABBVIE INC | ABBV | 0.35% |
 EXELIXIS INC | EXEL | 0.34% |
 TWIST BIOSCIENCE CORP | TWST | 0.33% |
 GILEAD SCIENCES INC | GILD | 0.33% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.33% |
 SPYRE THERAPEUTICS INC | SYRE | 0.32% |
 VERTEX PHARMACEUTICALS INC | VRTX | 0.31% |
 REGENERON PHARMACEUTICALS | REGN | 0.31% |
 ALKERMES PLC | ALKS | 0.3% |
 TG THERAPEUTICS INC | TGTX | 0.3% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.29% |
 PTC THERAPEUTICS INC | PTCT | 0.28% |
 INCYTE CORP | INCY | 0.28% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.28% |
 KRYSTAL BIOTECH INC | KRYS | 0.28% |
 CRISPR THERAPEUTICS AG | CRSP | 0.28% |
 REVOLUTION MEDICINES INC | RVMD | 0.28% |
 ROIVANT SCIENCES LTD | ROIV | 0.27% |
 BRIDGEBIO PHARMA INC | BBIO | 0.27% |
 ORUKA THERAPEUTICS INC | ORKA | 0.27% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 0.27% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.27% |
 VAXCYTE INC | PCVX | 0.26% |
 GRAIL INC | GRAL | 0.26% |
 CYTOKINETICS INC | CYTK | 0.26% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.25% |
 COGENT BIOSCIENCES INC | COGT | 0.25% |
 KYMERA THERAPEUTICS INC | KYMR | 0.25% |
 ERASCA INC | ERAS | 0.24% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.24% |
 IONIS PHARMACEUTICALS INC | IONS | 0.24% |
 TANGO THERAPEUTICS INC | TNGX | 0.23% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.23% |
 KODIAK SCIENCES INC | KOD | 0.23% |
 INSMED INC | INSM | 0.23% |
 DIANTHUS THERAPEUTICS INC | DNTH | 0.22% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.22% |
 VERACYTE INC | VCYT | 0.22% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.22% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.21% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.2% |
 IMMUNITYBIO INC | IBRX | 0.2% |
 CG ONCOLOGY INC | CGON | 0.2% |
 CAREDX INC | CDNA | 0.19% |
 RELAY THERAPEUTICS INC | RLAY | 0.18% |
 VIKING THERAPEUTICS INC | VKTX | 0.18% |
 BEAM THERAPEUTICS INC | BEAM | 0.17% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.17% |
 CELCUITY INC | CELC | 0.16% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.16% |
 DYNE THERAPEUTICS INC | DYN | 0.14% |
 SELLAS LIFE SCIENCES GROUP I | SLS | 0.13% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.13% |
 IMMUNOVANT INC | IMVT | 0.13% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.12% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.12% |
 DENALI THERAPEUTICS INC | DNLI | 0.12% |
 VIRIDIAN THERAPEUTICS INC | VRDN | 0.12% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.12% |
 NURIX THERAPEUTICS INC | NRIX | 0.12% |
 BIOHAVEN LTD | BHVN | 0.11% |
 DISC MEDICINE INC | IRON | 0.11% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.11% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.11% |
 VERA THERAPEUTICS INC | VERA | 0.11% |
 HYPERLIQUID STRATEGIES | PURR | 0.11% |
 GOLDMAN SACHS FIN GOV 465 INSTITUT | GOLDMAN.SACHS.FIN.GOV.465.INSTITUT | 0.1% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.1% |
 ADMA BIOLOGICS INC | ADMA | 0.1% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.1% |
 VERICEL CORP | VCEL | 0.1% |
 UNIQURE NV | QURE | 0.1% |
 CELLDEX THERAPEUTICS INC | CLDX | 0.1% |
 ABSCI CORP | ABSI | 0.1% |
 NOVAVAX INC | NVAX | 0.1% |
 PALVELLA THERAPEUTICS INC | PVLA | 0.09% |
 ARCUS BIOSCIENCES INC | RCUS | 0.08% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.08% |
 NEKTAR THERAPEUTICS | NKTR | 0.08% |
 PRECIGEN INC | PGEN | 0.08% |
 IMMUNOME INC | IMNM | 0.07% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.07% |
 STOKE THERAPEUTICS INC | STOK | 0.07% |
 XENCOR INC | XNCR | 0.07% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.07% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.07% |
 INHIBRX BIOSCIENCES INC | INBX | 0.07% |
 ANAPTYSBIO INC | ANAB | 0.06% |
 REPLIMUNE GROUP INC | REPL | 0.06% |
 ZENAS BIOPHARMA INC | ZBIO | 0.06% |
 VIR BIOTECHNOLOGY INC | VIR | 0.06% |
 JADE BIOSCIENCES INC | JBIO | 0.05% |
 KURA ONCOLOGY INC | KURA | 0.05% |
 TYRA BIOSCIENCES INC | TYRA | 0.05% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.05% |
 ARDELYX INC | ARDX | 0.05% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.05% |
 MANNKIND CORP | MNKD | 0.05% |
 VERASTEM INC | VSTM | 0.05% |
 ANNEXON INC | ANNX | 0.05% |
 VOR BIOPHARMA INC | VOR | 0.04% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.04% |
 GERON CORP | GERN | 0.04% |
 JANUX THERAPEUTICS INC | JANX | 0.04% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.04% |
 BICARA THERAPEUTICS INC | BCAX | 0.04% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.04% |
 CANDEL THERAPEUTICS INC | CADL | 0.04% |
 HEMAB THERAPEUTICS HOLDINGS | COAG | 0.04% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.04% |
 IMMIX BIOPHARMA INC | IMMX | 0.04% |
 MYRIAD GENETICS INC | MYGN | 0.03% |
 KAILERA THERAPEUTICS INC | KLRA | 0.03% |
 DAMORA THERAPEUTICS INC | DAMORA.THERAPEUTICS.INC | 0.03% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.03% |
 SAVARA INC | SVRA | 0.03% |
 REGENXBIO INC | RGNX | 0.03% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.03% |
 ACHIEVE LIFE SCIENCES INC | ACHV | 0.03% |
 PRIME MEDICINE INC | PRME | 0.03% |
 SANA BIOTECHNOLOGY INC | SANA | 0.03% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.03% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.03% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.02% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.02% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.02% |
 CLIMB BIO INC | CLYM | 0.02% |
 AVALO THERAPEUTICS INC | AVTX | 0.02% |
 CAPRICOR THERAPEUTICS INC | CAPR | 0.02% |
 SOLID BIOSCIENCES INC | SLDB | 0.02% |
 EDITAS MEDICINE INC | EDIT | 0.02% |
 SHATTUCK LABS INC | STTK | 0.02% |
 EMERGENT BIOSOLUTIONS INC | EBS | 0.02% |
 MONOPAR THERAPEUTICS INC | MNPR | 0.02% |
 DESIGN THERAPEUTICS INC | DSGN | 0.02% |
 ALTIMMUNE INC | ALT | 0.02% |
 ARS PHARMACEUTICALS INC | SPRY | 0.02% |
 OCUGEN INC | OCGN | 0.02% |
 AKTIS ONCOLOGY INC | AKTS | 0.02% |
 CABALETTA BIO INC | CABA | 0.02% |
 PROTHENA CORP PLC | PRTA | 0.02% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.02% |
 MIMEDX GROUP INC | MDXG | 0.01% |
 OVID THERAPEUTICS INC | OVID | 0.01% |
 NEUROGENE INC | NGNE | 0.01% |
 ASSEMBLY BIOSCIENCES INC | ASMB | 0.01% |
 AURA BIOSCIENCES INC | AURA | 0.01% |
 DREYFUS TRSRY SECURITIES CASH MGMT | DREYFUS.TRSRY.SECURITIES.CASH.MGMT | 0.01% |
 LEXEO THERAPEUTICS INC | LXEO | 0.01% |
 CRESCENT BIOPHARMA INC | CBIO | 0.01% |
 FAETH THERAPEUTICS INC | FTH | 0.01% |
 COMPASS THERAPEUTICS INC | CMPX | 0.01% |
 BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 INHIBRX INC CVR | INHIBRX.INC.CVR | 0% |
 NOVOB DC CVR | NOVOB.DC.CVR | 0% |
 VERVE THERAPEUTICS INC (CVR) | VERVE.THERAPEUTICS.INC..CVR. | 0% |
 OMNIAB INC - 15.00 EARNOUT | 2200964 | 0% |
| Sector | Weight |
|---|---|
|
Health care | 96.73% |
|
Financials | 0.66% |
|
All Others | 2.61% |
Direxion Daily S&P Biotech Bull 3X Shares (LABU) share price today is $256.96.
Yes, Indians can buy shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. To buy LABU from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. You can start investing in Direxion Daily S&P Biotech Bull 3X Shares (LABU) with a minimum investment of $1.
The 52-week high price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $341.93. The 52-week low price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $108.34.
The stock symbol (or ticker) of Direxion Daily S&P Biotech Bull 3X Shares is LABU.
Yes, you can setup SIP in Direxion Daily S&P Biotech Bull 3X Shares shares. Follow the below steps to create the SIP:
Here is the historical performance of LABU on the Vested app.
The expense ratio of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is 0.91%.
Link copied 
